Next Article in Journal
Comparing the Variants of Iron Oxide Nanoparticle-Mediated Delivery of miRNA34a for Efficiency in Silencing of PD-L1 Genes in Cancer Cells
Next Article in Special Issue
Design of A3B-Porphyrin Conjugates with Terpyridine as Potential Theranostic Agents: Synthesis, Complexation with Fe(III), Gd(III), and Photodynamic Activity
Previous Article in Journal
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection
Previous Article in Special Issue
Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(1), 214; https://doi.org/10.3390/pharmaceutics15010214
Action Date Notes Link
article pdf uploaded. 7 January 2023 14:38 CET Version of Record https://www.mdpi.com/1999-4923/15/1/214/pdf-vor
article supplementary file uploaded. 7 January 2023 14:38 CET - https://www.mdpi.com/1999-4923/15/1/214#supplementary
article xml file uploaded 17 January 2023 09:01 CET Original file -
article xml uploaded. 17 January 2023 09:01 CET Update https://www.mdpi.com/1999-4923/15/1/214/xml
article pdf uploaded. 17 January 2023 09:01 CET Updated version of record https://www.mdpi.com/1999-4923/15/1/214/pdf
article html file updated 17 January 2023 09:03 CET Original file -
article html file updated 1 March 2023 08:23 CET Update -
article html file updated 7 March 2023 21:23 CET Update https://www.mdpi.com/1999-4923/15/1/214/html
Back to TopTop